Lab finder: therascreen KRAS RGQ PCR Kit – the companion diagnostic for LUMAKRAS (sotorasib) and KRAZATI (adagrasib)

Companion diagnostics analyze a patient's DNA or RNA for actionable genetic alterations in order to help determine what treatment options may be best. Companion diagnostics are:

  • FDA-approved for IVD use
  • Sensitive tests that are clinically validated for specific targeted therapies for specific cancers
Visual for therascreen KRAS

The therascreen KRAS RGQ PCR Kit is a companion diagnostic test for use as an aid in identifying patients with non-small cell lung cancer (NSCLC) for whom treatment with LUMAKRAS (sotorasib) or KRAZATI (adagrasib) may be appropriate. The kit is a qualitative assay that can deliver results in less than two working days.

To find a lab that provides testing using the therascreen KRAS RGQ PCR Kit, please see the list of labs below and keep in mind this resource:

  • Is updated frequently, so continue to check back regularly for the most up-to-date information
  • May not represent all of the labs that offer testing using the therascreen KRAS RGQ PCR Kit
  • May not represent each location of the labs below, contact the lab of interest to find the nearest location

If you are a lab that offers the therascreen KRAS RGQ PCR test and don’t see your lab listed below, please contact your QIAGEN sales representative or contact QIAGEN at 800-426-8157, option 1.

Labs that provide testing of clinical NSCLC tumor tissue using the therascreen KRAS RGQ PCR Kit
QIAGEN has a broad portfolio of companion diagnostic products in development.
The therascreen KRAS RGQ PCR Kit is for in vitro diagnostic use.